Repligen
RGEN
#2458
Rank
C$10.43 B
Marketcap
C$185.41
Share price
-0.21%
Change (1 day)
-20.81%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): C$34.85 Million

According to Repligen 's latest financial reports the company's current earnings are C$0.70 Billion. In 2024 the company made an earning of -C$8.64 Million a decrease over its 2023 earnings that were of C$66.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$34.85 M-503.74%
2024 -C$8.64 Million-113.01%
2023 C$66.34 M-78.01%
2022 C$0.30 B33.37%
2021 C$0.22 B131.52%
2020 C$97.7 M101.31%
2019 C$48.53 M25.93%
2018 C$38.54 M105.61%
2017 C$18.74 M-11.46%
2016 C$21.17 M14.91%
2015 C$18.42 M20.26%
2014 C$15.32 M-51.49%
2013 C$31.58 M90.98%
2012 C$16.53 M
2010 C$0.23 M-103.81%
2009 -C$6.29 Million-223.84%
2008 C$5.07 M
2006 -C$3.41 Million229.64%
2005 -C$1.04 Million-89.16%
2004 -C$9.54 Million-16.86%
2003 -C$11.48 Million88.72%
2002 -C$6.08 Million-27.88%
2001 -C$8.43 Million-1.74%
2000 -C$8.58 Million85.93%
1999 -C$4.62 Million159.16%
1998 -C$1.79 Million85.71%
1997 -C$0.96 Million-70.83%
1996 -C$3.29 Million-72.41%
1995 -C$11.92 Million-60.63%
1994 -C$30.27 Million45.39%
1993 -C$20.82 Million39.45%
1992 -C$14.93 Million-32.3%
1991 -C$22.05 Million6.62%
1990 -C$20.68 Million1577.78%
1989 -C$1.24 Million-57.14%
1988 -C$2.88 Million-362.5%
1987 C$1.09 M-130.77%
1986 -C$3.57 Million136.36%
1985 -C$1.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.22 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$9.71 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$14.84 B 41,377.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.00 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.15 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.51 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.79 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.16 B 372.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.93 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-C$30.4 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA